ALAlphabet Inc.
Institutional investor · Portfolio as of Q2 2026
Top Holdings28 positions
SPACE EXPLORATION TECHN CORP | 551.2M | $94.2B | 95.0% | $170.86 | -4.85% | 1 qtr | New 99 |
PLANET LABS PBC | 35.2M | $1.2B | 1.2% | $6.32 | +172.05% | 15 qtrssince 2022-Q4 | Unchanged 0 |
AST SpaceMobile Inc | 8.9M | $794.7M | 0.8% | $24.06 | +111.82% | 6 qtrssince 2025-Q1 | Unchanged 0 |
CME Group Inc | 3.5M | $769.4M | 0.8% | $293.83 | -4.52% | 2 qtrssince 2026-Q1 | Unchanged 0 |
ARM Holdings PLC | 2M | $695.2M | 0.7% | $53.52 | +397.53% | 12 qtrssince 2023-Q3 | Unchanged 0 |
REVOLUTION MEDICINES INC | 2.9M | $551.8M | 0.6% | $28.69 | +561.40% | 11 qtrssince 2023-Q4 | Decreased 0 |
FRESHWORKS INC | 16.2M | $164M | 0.2% | $15.72 | -11.46% | 15 qtrssince 2022-Q4 | Unchanged 0 |
PARABILIS MEDICINES INC | 4.9M | $134.6M | 0.1% | $27.37 | +0.40% | 1 qtr | New 51 |
TEMPUS AI INC | 1.6M | $89.9M | 0.1% | $35.00 | +102.66% | 9 qtrssince 2024-Q2 | Unchanged 0 |
GITLAB INC | 2.7M | $83.2M | 0.1% | $54.31 | +1.44% | 15 qtrssince 2022-Q4 | Unchanged 0 |
UiPath Inc | 7M | $76.5M | 0.1% | $12.71 | +6.06% | 15 qtrssince 2022-Q4 | Unchanged 0 |
ETHOS TECHNOLOGIES INC | 3.6M | $65.7M | 0.1% | $11.17 | +230.89% | 2 qtrssince 2026-Q1 | Decreased 0 |
PRIME MEDICINE INC | 16.6M | $61.1M | 0.1% | $15.14 | -73.65% | 15 qtrssince 2022-Q4 | Unchanged 0 |
FERVO ENERGY CO | 1.8M | $51.5M | 0.1% | $29.23 | -52.96% | 1 qtr | New 42 |
PAYPAY CORP | 3.1M | $44.8M | 0.0% | $21.34 | -26.38% | 2 qtrssince 2026-Q1 | Unchanged 0 |
MAZE THERAPEUTICS INC | 1.4M | $41.4M | 0.0% | $11.42 | +137.39% | 6 qtrssince 2025-Q1 | Unchanged 0 |
Relay Therapeutics Inc | 1.4M | $26.4M | 0.0% | $14.94 | +19.68% | 15 qtrssince 2022-Q4 | Decreased 0 |
BRIDGEBIO ONCOLOGY THERAPEUT | 2.8M | $21.5M | 0.0% | $11.47 | -71.14% | 4 qtrssince 2025-Q3 | Unchanged 0 |
OSCAR HEALTH INC | 481,988 | $13.7M | 0.0% | $2.46 | +1256.50% | 15 qtrssince 2022-Q4 | Unchanged 0 |
BEAM THERAPEUTICS INC | 321,604 | $11M | 0.0% | $39.11 | -34.29% | 15 qtrssince 2022-Q4 | Unchanged 0 |
Alphabet Inc. manages $99.1B across 28 positions as of Q2 2026. Top holdings: SPCX (95.0%), PL (1.2%), ASTS (0.8%). Fund DNA: Concentrated Value. HoldingsIntel Score: 3/5.0.
Added 3 new positions, exited 1, trimmed 4. Top move: SPCX (NEW, conviction 99). Portfolio: $99.1B across 28 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR